Business Context and Reporting Period
This Form 8-K filing by BioSig Technologies, Inc. (not Streamex Corp.) reports on events occurring on August 17, 2018. The company is a Delaware corporation headquartered in Los Angeles, California. The report details an additional closing under a Securities Purchase Agreement with accredited investors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on a capital raise transaction.
- Transaction Date: August 17, 2018
- Shares Issued: 540,335 shares of Common Stock
- Warrants Issued: Warrants to purchase up to 270,170 shares of Common Stock
- Total Consideration Received: Approximately $1,231,963
- Price Per Unit: $2.28 per share plus accompanying warrants
- Warrant Terms: Series A (9-month, $1.50 exercise price) and Series B (3-year, $2.74 exercise price)
Material Changes Versus Prior Period
This filing represents a continuation of a financing round initiated on August 13, 2018. Prior closings between August 13 and August 16, 2018, resulted in the issuance of 1,234,321 shares and warrants for approximately $2,839,226. The August 17 transaction added to this aggregate capital raise.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or specific risk factors beyond standard securities law disclosures. The securities were sold unregistered under Section 4(a)(2) and Regulation D (Rule 506) of the Securities Act of 1933. The summary of the Purchase Agreement is qualified by reference to the full text filed as exhibits to the August 16, 2018, Form 8-K.
Investor Verification Checklist
- Verify the total aggregate capital raised from the entire financing round (August 13–17) by combining the $2,839,226 from prior closings with the $1,231,963 from this closing.
- Review the full text of the Securities Purchase Agreement filed as an exhibit to the August 16, 2018, Form 8-K for complete warrant terms and covenants.
- Confirm the company's current cash position and intended use of proceeds, as this filing does not specify the use of funds.
- Check for any subsequent filings regarding the registration rights or resale of the unregistered securities issued.